Table 2.
HER2 Testing Results
| IHC HER2 Protein Expression | Testing Method | |
|---|---|---|
| FISH HER2 Gene Amplification | ||
| Positive | 3+* | HER2/CEP 17 ratio >2.2 or |
| Average HER2 gene copy number >6† | ||
| Equivocal | 2+ | HER2/CEP 17 ratio of 1.8-2.2 or |
| Average HER2 gene copy number 4-6† | ||
| Negative | 0-1+ | HER2/CEP 17 ratio <1.8 or |
| Average HER2 gene copy number <4† |
NOTE. Definitions depend on laboratory documentation of the following elements: (1) proof of initial testing validation in which positive and negative HER2 categories are 95% concordant with alternative validated method or same validated method for HER2; (2) ongoing internal question-and-answer procedures; (3) participation in external proficiency testing; and (4) current accreditation by valid accrediting agency.
Abbreviations: IHC, immunohistochemistry; HER2, human epidermal growth factor receptor 2; FISH, fluorescence in situ hybridization; CEP 17, entromeric chromosome 17–specific probe.
* Defined as uniform intense membrane staining of >30% of invasive tumor cells.
† Signals/nucleus for those test systems without an internal central probe.